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Abstract
Biomaterials for reconstruction of bony defects of the skull comprise
of osteosynthetic materials applied after osteotomies or traumatic
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fractures and materials to fill bony defects which result from malforma-
tion,traumaortumorresections.Otherapplicationsconcernfunctional
augmentations for dental implants or aesthetic augmentations in the
facial region.
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For ostheosynthesis, mini- and microplates made from titanium alloys
provide major advantages concerning biocompatibility, stability and in-
dividual fitting to the implant bed. The necessity of removing asymp-
tomatic plates and screws after fracture healing is still a controversial
issue. Risks and costs of secondary surgery for removal face a low rate
ofcomplications(duetocorrosionproducts)whenthematerialremains
in situ. Resorbable osteosynthesis systems have similar mechanical
stability and are especially useful in the growing skull.
The huge variety of biomaterials for the reconstruction of bony defects
makes it difficult to decide which material is adequate for which indica-
tionandforwhichsite.Theoptimalbiomaterialthatmeetseveryrequire-
ment(e.g.biocompatibility,stability,intraoperativefitting,productsafety,
lowcostsetc.)doesnotexist.Thedifferentmaterialtypesare(autogenic)
boneandmanyalloplasticssuchasmetals(mainlytitanium),ceramics,
plastics and composites. Future developments aim to improve physical
and biological properties, especially regarding surface interactions. To
date, tissue engineered bone is far from routine clinical application.
Keywords: osteosynthesis, bone replacement, biomaterials, titanium,
craniofacial reconstruction
1 Introduction
In2004Warnkeetal.[157]describedaneartotalrecon-
struction of the mandibular arch, applying a computer
aid designed (CAD) individual-fit titanium mesh-“cage”
filled with xenograft bone-minerals, autograft bone mar-
row and recombinant human Bone-Morphogenetic-Pro-
tein(BMP)-7, which was implanted into a latissimus dorsi
muscle pouch in order to allow ossification. In a second
stage it was transplanted to the mandibular region with
microvascularanastomoses.Thiscasereportexemplarily
demonstratesthebroadspectrumofthepresentoptions
inreconstructivesurgeryandsurgicaluseofbiomaterials
for bone replacement in the skull: Autograft tissue, allo-
plastic materials, recombinant engineering, hormone-in-
ducedboneformation,microvascularsurgicaltechniques,
CAD und CAM (Computer Aided Manufacturing).
From a plentitude of data available in the literature, the
following survey aims to outline the substantial issues of
biomaterials for craniofacial reconstruction important in
otolaryngology, head and neck surgery.
Two major groups of biomaterials have to be differenti-
ated in this context: Biomaterials for osteosynthesis in
traumatologyandbiomaterialsassubstituteoraugment-
ation of bone. Biomaterials for ossiculoplasty and for
rhino-andotoplastyhavealreadybeensubjectofcircum-
stantial reviews in this rubric [13], [44]. Their particular-
ities shall not be repeated here although some overlap-
ping contents cannot be avoided.
2 Osteosynthesis
2.1 History
Dr. Carl Hansmann (1852–1917) who worked in the
hospital “St. Georg” in Hamburg, Germany pioneered in
plate fixation of fractures with a self-manufactured plate
osteosynthesissystemin1886[68].WilliamHalstedfrom
Baltimore improved the system around 1893 by implant-
ingthescrewssubcutaneouslyratherthanpercutaneously
as Hansmann did [129]. Nevertheless, severe corrosion
of the historical materials, poor hygiene and the lack of
antibiotics led to frequent cases of osteomyelitis and
implant-fracture. Only with the availability of antibiotics,
modernmaterialsandtheprincipalofaxialcompression,
proclaimed by Robert Danis in 1949, plate fixation be-
came a routine procedure in traumatology.
Luhr [101] realized the principal of axial compression for
mandibular osteosynthesis in the 1960s by using self-
locking compression plates with tapered screw heads
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sion-screw (MCS) plate is still used today.
Materials in frequent use for craniofacial applications
were stainless steel [140] and vitallium [101], an alloy
fromcobalt,chromeundmolybdenum.Althoughtitanium
had been in clinical use since 1966 [74], it was Bråne-
mark in 1983 [21] who outlined the superior biocompat-
ibility and favorable mechanical properties of this metal.
In addition, biodegradable plates and screws were avail-
able since the mid 1990s.
2.2 Metals
2.2.1 Stainless steel
High-alloyed stainless steel contains variable amounts
of nickel, chrome, manganese, vanadium and/or molyb-
denum.Invivo,thecorrosionresistancemaybeimpaired
under certain ambient conditions which may lead to
crevice corrosion. Clinically, the corrosion products may
leadtotheformationofgranulationtissueonthesurface
thus causing sensitization. As steel shows a higher
elasticity modulus than bone tissue (ratio of the uniaxial
stress over the uniaxial strain in the range of stress)
stress shielding effects may occur and lead to bone re-
sorptionin suchcasesoflongboneosteotomy wherethe
metal material carries the greatest part of the load.
Even though great mechanical stress is rather rare in
craniofacial surgery (an exception may be the mandible)
stainless steel is rarely used for craniofacial osetosyn-
thesis today.
2.2.2 Cobalt based alloys
Inthe20thcentury,newdevelopmentsinthemetalwork-
ing industry led to the production of an iron-free molyb-
denous cast alloy on a chrome and cobalt basis. These
wereintroducedtothemarketunderthenameVitallium
®
by Dres Reiner Erdle and Charles Prange (Stryker
Howmedica, former Austenal Laboratories), at first only
for dental indications. Thereafter Vitallium
® served as a
very corrosion-resistant material for several in dications
in the field of endoprosthesis and osteosynthesis. Luhr
was the pioneer of craniofacial mini-osteosynthesis-sys-
tems based on Vitallium (Luhr
® Modular Craniomaxillo-
facial/Mandibular Fixation System, Leibinger Co.) [99],
[100], [101]. Similar to stainless steel, cobalt alloys may
also cause unwanted secondary effects due to corrosion
products.Thisincludeselevation[164]andevenaccumu-
lation[17]ofmetalionsintheblood.Regardingthegreat
number of implants throughout the world these sporadic
cases of secondary effects are more or less negligible
[131], [138], this being the reason for the systems suc-
cessful use today.
2.2.3 Titanium
Titanium is the most biocompatible and corrosion-resist-
ant metal [4], [127], its elasticity modulus corresponds
totheelasticitymodulusofthebonemorethananyother
metal does [70], [83], therefore titanium is increasingly
drivingothermetalsoutofthe“craniofacialosteosynthe-
sis market”.
2.2.3.1 Chemical and mechanical properties
Titanium is a white metallic transition element with an
atomicnumberof22.Eventhoughtitaniumiscommonly
found in the lithosphere the industrial production of
“pure” titanium is complex and therefore expensive, as
itmustbeextractedfromironoreviahighlyenergyintens-
ive methods. Commercially obtainable “pure” titanium is
classified into four quality grades. “Pure” titanium refers
to an amount of less than 1% of additives like nitrate,
carbon, hydrogen, oxygen or iron. These are specified in
ISO 5832-2:2000-08. Titanium osteosynthesis material
regularlyconsistsof alloys, e.g. Ti-6Al-4V (6% aluminium,
4%vanadium)orTi-6Al-7Nb(6%aluminium,7%niobium),
as standardized in ISO 5832-3.
Titaniumischaracterizedbyhighstabilityatalightmass.
This makes titanium a popular material for mechanically
stressed and equally lightweight components (e.g.
aerospaceindustry).Itselasticitymodulus(105kN/mm
2)
is well above the modulus of the human bone (approx.
20 kN/mm
2) but only half as large as the modulus of
stainless steel or cobalt alloys, therefore making stress
shielding – effects less likely.
Anapprox.10µmthicksuperficiallayeroftitanium-oxide
develops spontaneously, this is not only responsible for
corrosion-resistancebutalsofortheadhesionofglycopro-
teins in vivo, therefore being of great importance for the
biocompatibility. In despite of this protectional layer a
slight amount of corrosion occurs as a result of flexure
undermechanicalstressandalsofrictionbetweenosteo-
synthesis screws and plates [139]. This phenomenon
may be intensified in the presence of macrophages
through the production of H2O2 [109].
2.2.3.2 Toxicity
Titanium shows very low toxicity both in its ionic and also
in its particle form. Titanium ions are subject to renal ex-
cretion [78]. Rulite, a titanium corrosion product, accu-
mulates in lymph nodes, liver, spleen, bone marrow and
the brain [29].
Higher toxicity potential arises from alloy additives:
Aluminiumions,whicharealsosubjecttorenalexcretion
[108], may accumulate in cases of impaired renal func-
tion [55] and act neurotoxic. However all reported cases
of aluminium accumulation detectable in the serum and
hair relate to hip implants and not to craniofacial appli-
cation [42], [150]. Also there have not yet been stated
any cases of clinically relevant toxic accumulations,
therefore the systemic toxicity may be regarded as negli-
gible.
Vanadium is considered to be a micronutrient with a yet
unidentified function. Vanadium only causes systemic
toxic effects in high concentrations [38], [43].
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Neumann et al.: Biomaterials for craniofacial reconstructionFigure 1: Osteosynthesis of a fracture of the mid-face (“Tripod”-fracture) with microplates and screws from titanium alloys:
a and b: Axial und coronal computer tomography with demonstration of the fractures; c and d: Intra- and postoperative
demonstration of the miniplate osteosynthesis; e: Evaluation of postoperative position of the materials by conventional x-ray.
In a synopsis of the literature there currently is no indi-
cation for clinically relevant toxicity caused by titanium-
alloyed craniofacial osteosynthesis systems. Possible
toxicity in the tissue surrounding the implants is also
negligible. Animal tests also have shown no effects on
skeletal muscles [121]. While localized reaction of mu-
cous membranes are extensively described in dental im-
plantology [112], only very few reports exist about local-
ized reactions caused by screws protruding into nasal
sinuses and therefore gaining contact to the mucosa.
According to Brunner [23] this mucosal contact may give
rise to inflammatory complications. The direct contact of
mucosa and titanium does not cause clinical problems,
as has been shown in titaniummesh reconstruction of
the frontal and maxillary sinuses (see below) [84], [93].
2.2.3.3 Sensitization
Otherthanwithnickel,cobaltundchromium,sensitization
through titanium is rare [147]. Though individual cases
have been described for orthopedic applications and
pacemakerimplants, no type IV-reactions have been de-
scribed for craniofacial applications to date. This also
applies to aluminium und vanadium. Overall, allergic re-
actions do not seem to play any role concerning the
craniofacial application of titanium alloys.
2.2.3.4 Cancerogenity
Animal tests do not show any indication of cancerogenity
of titanium alloys [97], [144]. Individual cases of malig-
nant tumors in the tissue surrounding titanium implants
(pacemakers [56], mandibular plates [58]) remain spec-
ulation, pathogenically. Regarding the great amount of
titaniumimplantsusedthroughouttheworldcancerogen-
ity is practically ruled out.
2.2.4 Systems
Today, a wide variety of systems with numerous forms of
plates (miniplates, microplates, Figure 1 and Figure 2),
meshes and screws are available for clinical use [31],
[138].Theindividualcolouroftheplatesandscrewsdoes
not depend on pigmentation but is due to surface anod-
isation with which the manufacturers try to give their
products a certain recognition value. Meanwhile rectan-
gular plates, which were commonly used in earlier years,
have been replaced by modular elementary plates and
narrow, round-edged arched plates mainly because of
their improved intraoperative adaptability [118]. Unlike
with the former AO-system (Arbeitsgemeinschaft für Os-
teosynthesefragen), it now is not necessary to tap a
thread but simply to pre-bore for the self-tapping screws.
Thanks to their ductility (plasticity under overstressing)
titanium plates can de adjusted easily intra-operatively.
These systems may be sterilised and are re-usable. The
mechanical integrity – as measured by maximal flexure
before breaking – is not significantly reduced even after
50 cycles of autoclaving [1].
2.2.5 Removal of osteosynthesis material
Titanium plates and screws that become symptomatic
duringthehealingphaseofafracture,mustberemoved.
Symptoms include: infection, foreign body response,
wound dehiscence, extrusion, plate fracture, migration,
pain, thermal sensitivity, growth disturbance in children,
renal failure (possible accumulation of corrosion
products). Clinical trials detect infection as the most
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Neumann et al.: Biomaterials for craniofacial reconstructionFigure 2: Osteosynthetic care of a fracture of the anterior frontal sinus wall: a: Axial CT with demonstration of the fracture;
b: Operative management by means of miniplate osteosynthesis from titanium after coronal incision.
commonreasonfortheremovalofosteosynthesismater-
ial: Over a 4-year period Bhatt et al. [16] had to remove
32of308oro-maxillo-facialmini-platesimplantedin153
patients due to infectious complications. Murthy et al.
[111] removed only 6 of 163 craniofacial titanium plates
(76patients)overa10-yearperiod,allcasesduetoinfec-
tions. Other authors declare infection rates at approx.
7–10% [9], [77], [128].
The removal of asymptomatic plates and screws after
complete fracture healing is subject to many controver-
sies:
Brunner generally recommends plate removal referring
to possible infectious complications [23], [24] this being
lessbasedonthematerialpropertiesbutonthefactthat
screws which protrude into the nasal sinuses (Figure 3)
andthereforegain contactto the highly reactive respirat-
oryandpotentiallycontaminatedmucosaprovideanideal
infection-ductwhichenablesbacterialdisseminationand
therefore osteitic complications [23], [24]. The local im-
munereactionismainlybasedonmacrophagealinterac-
tion with the implant surface [7]. Titanium ions may en-
hance implant-conducted bone-resorption in vitro and in
vivo through activation and secretion of cytokines [156]
which in turn facilitates infection. Other reasons for the
removal of implanted material may comprise: patients
requests, radiological artefacts, palpability, visibility,
thermal sensitivity.
Figure 3: Osteosynthetic screw protruding into the lumen of
thefrontalsinus(screwfromsiliconnitride,animalexperiment,
minipig)
Arguments against the removal of asymptomatic plates
are mainly bases on the need for subsequent removal
with accordingly (low) morbidity and on the high biocom-
patibilityoftheimplantmaterial.Othertitaniumimplants
remain inside the patient (pacemakers, articular im-
plants), the difference here being that titanium plates
and screws are practically “functionless” after complete
fracture healing.
Steinhart and Schröder [141] recommend a removal de-
pendingonthelocalisation(maxillarysinuswall,alveolar
ridge) and also generally for children.
Insummarythereisnoconsentinthequestionofremoval
of asymptomatic titanium plates and screws in cranio-
facial applications because of the lack of scientifically
proven indications or contraindications for either ap-
proaches. Other than in most European countries, the
majority of asymptomatic plates and screws are not re-
moved in the U.S. [151]. It is subject to discussion if
economical reasons are of greater relevance in those
cases.
2.3 Resorbable osteosynthesis systems
The demand for resorbable osteosynthesis systems for
facial fractures and osteotomy stabilization arises from
theabovementionedcontroversiallydiscusseddisadvant-
ages of metal implants:
• Necessity of a second operation for the removal of
implants due to loosening of screws, palpability or
visibility of implants
• Thermal sensitivity
• Radiological artefacts
• Implant translocation in the growing skull of children
The avoidance of immobilization-caused osteoporosis
may be seen as a biological argument for the use of re-
sorbable material. Studies have shown that the resorp-
tion-dependant weakening of the implants leads to an
earlier functional exposure and therefore faster restruc-
turing of the fracture gap [60].
Even though the resorbable features were already well
known from suturing material (Dexon
®, Maxon
®, Vicryl
®,
PDS
®), the era of synthetical resorbable implants made
from lactic acid and glycolic acid (Polylactic acid – PLA,
Polyglycolic acid – PGA) began in the 1960s with studies
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that resorbable miniplates and screws were widely intro-
duced to clinical routine. There are other resorbable
polyesters known – apart from the above mentioned
polyesters and their copolymers: Polycaprolaktone, poly-
hydroxybutyrate, polytrimethylcarbonate, polyurethane.
Today there is a vast number of publications on the sub-
ject of resorbable polymers.
2.3.1 Structure of resorbable polymers
The basic elements of polylactic acid (PLA) and polygly-
colic acid (PGA) are units of lactic acid or glycolic acid.
Lactic acid is a chiral molecule (two optical active forms)
and may be present in its L- or D-configuration. Hence
polylactidesareonlycomposedofmoleculesofthesame
configuration,e.g.poly-L-lactide(PLLA)orofthesterically
differing basic molecules, e.g. poly-D, L-lactide (PDLLA).
By catalytically mediated ring-opening polymerization
high-molecular polymers are synthesized from the basic
molecules. The physical properties of the high-molecular
polymersdependonmolecularweight,linearorbranched
architecture and amorphous or crystalline structure of
the polymer chains. By alteration of the components
polymersandcopolymers(e.g.PLLA/PDLLA)withdifferent
properties (tensile strength, flexural strength etc.) may
be synthesized [12], [39], [60], [67], [123], [148], [152],
[154].
2.3.2 Degradation and degradation time
Resorptionofpolymersgenerallyoccurseitherbyphoto-,
thermo-, mechanical oder chemical degradation. In vivo,
chemical degradation plays the most important role,
thereforeanaqueousenvironmentisnecessarytoenable
hydrolysis to degrade the polymers into short-chained
fragments. These lowmolecular fragments are phagocy-
tosedandmetabolizedbymacrophagesandpolymorpho-
nuclear leukocytes. The resulting monomers are natural
byproductsofanaerobicmetabolism.Lactideisconverted
to pyruvate by lactate dehydrogenase and is then either
usedforgluconeogenesisorisdegradedtocarbondioxide
and water via the citric acid cycle. These final products
are either exhaled or excreted [20].
The time period of hydrolytic fragmentation depends on
temperature, pH-value, availability of water, mechanical
strain and also on the configuration of the polymers
(composition, production, molecular weight, crystal linity
etc.):LowpH-values(asininflammatedtissue)increases
degradationin terms of an autocatalyticprocessthrough
the released acidic monomeres. Polymers with highly
crystalline regions are degraded more slowly due to the
fact that hydrolytic degradation commences in the
amorphous regions.
As the degradationspeed is mainly determined by hydro-
lytic degradation– and not so much by phagocytosis and
metabolisation – it may be directed by the configuration
of the polymer.
The absolute degradation times quoted in the literature
differ remarkably, depending on the configuration of the
individual polymers and also because of the different
types of studies (animal test – clinical trial). High crystal-
line polymers made from PGA may be entirely resorbed
after 6 months time [155], whereas high crystalline
residues of PLLA-implants can be traced after more than
5yearstime[14].Overlookingtheabundanceofpublica-
tionsonthistopicastandardreferencedegradationtime
of approx. 12 months may be regarded for the broadly
available PLLA and PGA copolymers.
2.3.3 Mechanical properties of resorbable
polymers
Comparedtometallicsystemsresorbablematerialshows
lesser tensile strength. This however has less influence
on the immobilisation of fractures yet large influence on
the handling of resorbable plates and screws during im-
plantation, for instance threads still have to be tapped
asselftappingscrewsdonotyetexist.Incasethescrews
donotexactlypassthroughthethread,frictionforcemay
cause breaking of the screw. This circumstance was
consideredwhenaddingapredeterminedbreakingpoint
above the screw head (Figure 4). Because of the same
problem there are no plate systems for interfragmental
compression, having mentioned that this is not regularly
necessary apart from the mandible. Another essential
differencetothemetallicsystemsisthefittingoftheplate
to the individual flexion of the implant bearing. Flexure
of the plates is only possible at a temperature above the
particular glass transition temperature (Tg) of approx.
60°C. Today the manufacturing companies offer several
methods for short term heating of the plates (heating
pads and probes), even short heating in heated baths is
possible.Onemustkeepinmindthatunregulatedheating
may alter the molecular structure thus effecting stability
anddegradationproperties.Thisequallyappliestosteril-
ization as there are no resterilisable reserve containers.
Just like the degradation properties the mechanical
properties also depend on the configuration of the poly-
mer, crystallinity, molecular weight and hence on the
degradation time. The manufacturing process (injection
moulding) and sterilization process may also lead to an
alterationof stability [61]. At the time of implantationthe
plates and screws are equally firm as titanium plates. A
loss of solidness due to hydrolysis varies enormously
determined by its composition. A copolymer miniplate
andminiscrewsystemforfacialfractures(PLLA/PGAratio
of 82/18, Lactosorb
®) described in 1996 by Eppley et al.
[51] showed 70% of the initial stability after 2 months
time[123].Animaltests[162]andclinicaltrials[8],[52],
[67], [76], [92], [151] also show sufficient stability. Im-
plant fractures are rare occasions [66], [86].
2.3.4 Clinical use
The shaping effects of the available systems are similar
to those of metallic systems (Figure 4).
5/17 GMS Current Topics in Otorhinolaryngology - Head and Neck Surgery 2009, Vol. 8, ISSN 1865-1011
Neumann et al.: Biomaterials for craniofacial reconstructionFigure 4: Resorbable osteofixation system from a copolymer (PLLA/PGA ratio 82/18, Lactosorb
®): a: Different shapes of the
plates, right below: orbital floor plate; b: Predetermined breaking point (arrow) of the screws
In 1999 Wiltfang [162] investigated the problem of
passiveintraosseoustranslocationcomparedtotitanium
in the growing minpig skull. Passive translocation is
definedasanintracranialdisplacementoftheplatesdue
to the growth of the skull. The study also showed translo-
cation of resorbable plates however this never exceeded
the tabula interna. In clinical routine the resorbable sys-
tems have proved themselves for for cases of osteosyn-
thesis in adolescence [8], [49], [62], [76], [142].
Larger plates also qualify for reconstruction of the floor
of the orbit in cases of blowout fractures [5]. One should
also regard that resorbable systems have successfully
been used for refixation of fractures and after chondrot-
omy/osteotomy of the thyroid cartilage [15].
2.3.5 Disadvantages of resorbable
osteosynthesis systems
Polymers are considered to be primarily biocompatible,
as their degradation products are entirely metabolized,
yet their resorption resembles a foreign body response
with accumulation of macrophages and granulocytes.
Cases of fistulas, osteolysis and also soft tissue swelling
have been described [19], [146], [159].
The necessity to tap a thread and to exactly fit the screw
into it requires time and may give rise to screw breakage
and an increased waste of material. Newer technologies
areaimedatproducingself-tapping(e.g.TACKER
®-System,
Inion Ltd. Tampere, Finland). Another time-saving alter-
native may be the “Ultrasonic Bone Welding”-technique
in which resorbable pins are applied in place of screws.
Subsequently the polymers are – to make it simple – li-
quifiedthroughultrasoundenergy,thencompressedinto
the Haversian Canals where they can resolidify. This re-
sults in an intense and reinforced implant-bonecom-
pound.Clinicaltrialresultsareavailablemeanwhile[47].
2.4 Alternative materials
The above mentioned disadvantages of metallic and re-
sorbable osteosynthesis material justify the need to
search for alternative materials, as the currently known
systems are not entirely ideal.
Silicon Nitride
Themechanicalstrengthofsiliconnitride(Si3N4)isapprox.
twice as large as the strength of aluminium-oxide
ceramics (Al2O3) used for hip implants, therefore Si3N4
qualifies as implant-biomaterial for indications with high
mechanicalstrain.ThebiocompatibilityofSi3N4hasbeen
proven in many studies [6], [41], [75], [88], [114], [115].
So far, experiences with ossicular prostheses made from
Al2O3 have shown that ceramic materials have good
biocompatibility and mechanical strength even when
gaining contact to respiratory mucosa [79], [125]. A
ceramic osteosynthesis prototype [117] in the minipig
model showed satisfactory intraoperative handling, reli-
able stabilisation of the fracture gap and good healing
attributes for osteosynthesis of the anterior wall of the
frontal sinus. Both the finite element analysis and also
histologicalpreparationandpracticalexperienceshowed
that especially the ceramic screws proved to be mechan-
ically reliable and bioinert (Figure 3).
Theessentialdisadvantageofceramicplatesistheirlack
of ductility which in turn does not allow any modelling of
the plates to the shape of the bone. Combinations of ti-
taniumplatesorresorbableplatesandSi3N4-screwsmight
be worth taking into consideration [23]. The infection
problem of screws protruding into the sinuses does not
applytotheinertSi3N4-screws.Thiscouldmakearemoval
of implant material superfluous. The technically complex
production of ceramic screws remains as the main prob-
lemmakingaclinicalapplicationinthenearfuturerather
unlikely.Apartfromosteosynthesispurposesthematerial
may qualify for other indications in craniofacial bone
substitution.
3 Bone substitutes
3.1 General considerations
The bone metabolism is a complex mechanism which is
not fully understood to date. The bones ability for regen-
erationisdependantonthesizeofthesubstantialdefect.
Above a “critical size defect” regeneration by means of
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Neumann et al.: Biomaterials for craniofacial reconstructionFigure 5: Historical plate of “Supramid” for reconstruction of anterior frontal sinus wall. Origin: Boenninghaus 1960 [18].
autologous bone material does not occur. These cases
(i.e. congenital,traumaticand tumorous defects) require
anapplicationofbonesubstitutes.Otherindicationsmay
concern either functional, e.g. reinforced bearing for
dental implants (Sinus lift, Alveolar ridge augmentation)
or aesthetical matters, e.g. facial augmentation (chin,
zygomatic arch, nose).
The biological interaction of bone and bone substitution
material is characterised as follows:
Substitution: Complete resorption and replacement of
the implant by autologous bone material. In cases of to
fast resorption an (unwanted) fibrous interlayer may oc-
cur.
Osteoconduction: This describes the materials property
to direct the growth of bone tissue due to its geometric
configuration. For bony regeneration it is necessary to
have a scaffolding along which the osteoblasts can mi-
grateintothedefect.Evidencesuggeststhatinterconnect-
ingporesof150to450µmareidealforthat.Forexample
calciumphosphateandbioglasshavefavorableosteocon-
ductive properties.
Osteoinduction: Describes the differentiation of mesen-
chymal precursor cells into osteoprogenitor cells and
subsequently endochondral ossification.
Osteostimulation: Activation of differentiated bone cells
and stimulation of bone metabolism.
An ideal bone substitute material should be biocompat-
ible, osteoinductive and osteoconductive, resorbable,
malleable, mechanically stabile, synthetically fabricable,
long-time storable, resterilisable and inexpensive. Unfor-
tunately none of the materials available to date meet
these requirements. This explains the large amount of
materials commercially available (apart from autologous
bone material). Throughout the world bone substitute
material follows blood and blood-based products as the
second most frequently used tissue substitute. The de-
mand for alloplastic material is generally justified by the
disadvantagesofautologousbonematerial:Necessityto
source bone graft with donorsite morbidity and scarring,
prolongation of operation time, highly complex operative
procedures, limited individual shape modulation, limited
availability in cases of large defects. This is in opposition
to the problems involved with alloplastic material: ex-
penses, storage, biocompatibility/rejection. The field of
ORL poses especially high requirements to alloplastic
materials due to the proximity of bone and mucous
membranes.Thesegeneralproblemsofbonesubstitution
are not new, as Boenninghaus mentioned in 1960 (Au-
thors translation):
“It is indubitable that the usage of bone material is to be
seen as the physiological technique and therefore once
again has been recommended lately. On the other hand
alloplastic material offers a series of advantages which
should not be underestimated” [18].
Using the example of bone substitution in the frontal si-
nuses it becomes evident, that the materials success is
not only dependant on its properties but also even more
onthequestionifsufficientaircirculationisensuredand
if the mucosa is fully resected in cases of obliteration.
Otherwise relapse or rejection may occur independent
from the material used. Boenninghaus used Supramid
plates (synthetic, non-resorbable polyamide) for the
“primary frontal sinus plasty” (Figure 5) and concludes
(Authors translation):
“Astheplatescouldnotbeembeddedintothetissueand
also were not entirely surrounded by soft or bony tissue,
foreign body infections occurred in the operated frontal
sinusesinwhichplatesurfaceswereexposed.Thesecre-
tion from the operated sinuses required removal of the
plates after a few months” ([18], p. 39).
In the past, mastoid obliteration has shown rather disap-
pointingresultswhicharemainlyattributedtothedifficult
implant location rather than the implant material.
Anotherprincipalquestionwhenselectingtheappropriate
materialisalwaystheconsiderationofmechanicalstress
to which the implant is exposed to at the specific implant
location. For most materials the following rule applies:
Mechanical resilience decreases with an increase of
osteoconductivity (see above) and resorbability, e.g. tri-
calciumphosphateceramics:highosteoconductivity,low
mechanical resilience and vice versa; aluminium oxide
ceramics: no osteoconductivity, high mechanical resil-
ience.
Theporosityandporesizearealsoimportantparameters
fort the possibility of tissue ingrowth into the substitute
material and to what extent the material is osseointeg-
rated or transformed into vital bone tissue. Normal corti-
calbonehasaporesizeof1to100µm,cancellousbone
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connection of pores (interconnecting or blind pores) de-
termine nutrient diffusion as well as cell migration and
adhesion. A pore size of 100 to 500 µm is regarded as
the ideal precondition for the ingrowth of surrounding
bone tissue into the implanted material [89]. Pores
smallerthan100µmleadtofibrovascularencapsulation
of the implant.
Anextensiveoverviewofthecommerciallyavailablebone
substitute materials, trade names, introduction to the
market, administration form, durability etc. can be found
in the internet at http://www.dentalkompakt-online.de/
62_produktliste.html (see also Table 1, presentation
Maier http://www.egms.de/en/journals/cto/2011-8/
cto000059.shtml).
3.2 Bone
3.2.1 Autologous bone
Autologousbonehasbeenusedasbonesubstitutesince
the 19th century [102] and is considered to be the bio-
material per se. Different donor sites (calvaria, rib, iliac
ala, tibia, scapula, sternum) were already described in
the early 20th century (“spongiosaplasty”). Vascularised
bone transplantsusuallyderive from the tibia or iliac ala.
The rate of donorsite morbidity, which is always men-
tioned as an argumentfor the usage of alloplasticmater-
ial along with the time exposure, varies considerably in
the literature: In an overview of more than 12,000
cranioplasties with autogenic calvarian bone the compli-
cation rate was 0.08% [85]. Other authors quote compli-
cation rates of donor sites as high as 8.6% [166]. Mono-
cortical bone retrieval (calvarian split) is expedient in
ordertoavoiddonor-sitemorbidity,especiallywhenusing
a coronal incision [72], [113], for example in the recon-
struction of the anterior or posterior frontal sinus wall.
Many studies have proven the efficacy of suchlike autol-
ogous bone transplants for the reconstruction of frontal
sinus walls [95], [136], [145], [158]. Autologous bone
grafts also qualify for the reconstruction of the nasal
skeleton, orbit floor and anterior maxillary sinus wall, in
these cases the graft can be obtained via a small retrio-
auricular parietotemporal incision.
The great advantage of autologous bone grafts is the
complete biological integration due to their natural
biocompatibility. This makes them especially suitable for
casesinwhichalloplasticbone-plastieshavebeenunsuc-
cessful, in cases of infectious complication or in the
situation of close contact of bone to respiratory mucosa
(nasal sinuses).
The essential disadvantage of autogenic bone grafts is
thelimitedpossibilityoftransplantformingandmodelling,
especiallywhenusednotonlyforfunctionalbutforappar-
ent aesthetic bone defects (e.g. large frontal defects of
themarginoftheorbit).Also,thedataconcerningresorp-
tion of autologous grafts varies considerably. Due to
possible resorption autogenic grafts are not recom-
mended for facial augmentation [32], [64], [110].
3.2.2 Allograft bone
Allograftboneisharvestedfromhumandonors.Theentire
organiccomponentsareindustriallyremovedresp.denat-
urated,inactivatedandsterilized:Thishappensmechan-
ically in ultra-sound baths, through denaturating ethanol
lavage,antimicrobiallavageand/orgammaradiationwith
the result of obtaining exclusively anorganic bone matrix
for implantation. These implants have a normal bone
structure. Some authors add some autologous bone
marrow in order to support the transformation into vital
bone substitute [143]. Still, concerns remain regarding
the safety, healing rates and long-term stability of such
implants [50], [69]. To date this implant form is mainly
used in orthopedic surgery.
3.2.3 Xenogenic bone
The application of xenogenic bone grafts has already
been taken into consideration by Adolf Bardeleben from
Greifswald in 1859 (Lehrbuch der Chirurgie und Opera-
tionslehre, Zweiter Band, Georg Reimer Verlag 1859,
Seite316–317).Todayimmunogenityandproductsafety
regardingthetransmissionofinfectiousdiseasesarethe
main concerns about the application of xenograft bone.
Xenograftboneistusuallyofbovineorigin.Thedeprotein-
izationprocessissimilartothatofallogenicbone.Mineral
xenografthasbeenusedindentalsurgeryformanyyears
(Bio-Oss
®,GeistlichBiomaterials,Baden-Baden,Germany).
3.2.4 Demineralised bone
Dematerialized bone is also harvested from human
donors.Thedemineralizationisusuallyperformedthrough
acidification resulting in a matrix containing type-I-colla-
gen and osteoinductive growth factors, particularly BMP
(Bone Morphogenetic Proteine) [132]. Lyophilization
makes the material storable. The porous material can be
easily formed and remodelled intraoperatively. Due to its
composition the material is both osteoinductive and os-
teoconductive. It serves as a matrix for the ingrowth of
bone material but is not load resistant until fully ossified
(within 4–10 months). Both manufacturers and many
publications attest high safety regarding immunogenity
and the transmission of infectious diseases (esp. HIV)
[107], [69].
3.3 Alloplastic material
3.3.1 Metals (Titanium)
Titaniumimplantsfortherepairofcalvarian,orbitofrontal
and orbitozygomatic defects are available as meshes or
prefabricated. The question about removal of the mater-
ial does not arise, as larger defects must be bridged
permanently and a removal would also demand a larger
operative approach [93].
Meshes are available in two thicknesses: 0.1 mm thin
meshes (e.g. M-TAM: Laser-perforated micro titanium
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and shaped individually and cut with scissors. They are
fixated with titanium screws and are convenient for
primaryfractureswithbonesubstanceloss.Micro-Meshes
have also proven appropriate for the reparation of the
anteriorfrontalsinuswallshowingsuccessfulrepneumat-
ization [93].
Thicker meshes (e.g. Micro Dynamic Mesh 0.3 and 0.6
mm Stryker Leibinger) are suitable for the treatment of
contour irregularities. The area of bone loss in complex
3-dimensional reconstruction of acute traumatic defects
of non load-bearing areas should not exceed 25 cm
2.
Meshesarealsonotrecommendedafterradiationtherapy
[93].Forfurtherdetailsseechapter3.3.1.1,presentation
Maier http://www.egms.de/en/journals/cto/2011-8/
cto000059.shtml.
Individualtitaniumimplants[33],[54],[133]aresuitable
forsecondaryreconstruction.Suchprefabricatedtitanium
implants are milled from a solid titanium block per Com-
puter Aided Manufacturing (CAM) (see chapter 3.3.1.2,
presentation Maier http://www.egms.de/en/journals/
cto/2011-8/cto000059.shtml) after acquisition of CT-
data and Computer Aided Design (CAD). The accuracy is
0.25 mm to the defect edge with a titanium plate thick-
ness of 1.5 mm. The required equipment is expensive
and not widely available.
Thermosensitivityandlimitedpossibilityofintraoperative
shaping and remodelling (in contrast to glass ceramics,
see below) are mentioned as the major disadvantages
of metals as bone substitutes.
3.3.2 Ceramics
3.3.2.1 Bioactive glass-ceramics
The first synthetically manufactured bioactive glass-
ceramic (1971) Nova Bone
®, Bioglass
® is composed of
45%silicondioxide,45%sodiumoxide,5%calciumoxide
(CaO)and5%phosphorousoxide(P2O5).Thephysicaland
biological properties of glass-ceramics can be varied by
alterationofthefractionofoxidesandtheCaO/P2O5ratio.
The composition makes it highly reactive in liquid media:
Through scission of silicon-oxagen bonds silicic acid is
formed which then shows gelatine condensation at the
surface and holds the glass particles together. In this
gelatine layer calcium phosphate crystallises and forms
anapatitelayer.Thelatterreactswithcollagen,mucopoly-
saccharides and glycoproteins which results in fixation
of the material to the surrounding bony tissue and at the
same time only showing minimal fibrous encapsulation
[71]. Because of the proven osteostimulation at the sur-
face of glass-ceramics these may be regarded as bio-
active. In comparison to hydroxyapatite (see below) the
ceramicsshowalargeramountofnewlysynthesizedbone
substance which also is more similar to natural bone
substance [28], [120]. Despite the intensive bond
between bone and implant, substitution of the material
does not occur.
Even though the elastic modulus of glassceramics (ap-
prox. 30 kN/mm
2) is near to the modulus of human bone
(seeabove)theamorphousglassmeshworkisfragileand
therefore unsuitable for load-bearing indications. The
main field of application remains in Dental Surgery (aug-
mentationofalveolarridgeandperiodontaldefects,sinus
lift) and also in the reconstruction of the calvarium [65]
andtheflooroftheorbit[2].Bioactiveglass-ceramics(as
well as hydroxyapatite) have also been used for oblitera-
tion of the frontal sinus [2], [119] (see chapter 3.3.2.1,
presentation Maier http://www.egms.de/en/journals/
cto/2011-8/cto000059.shtml).
Duskova et al. [46] reported an extrusion rate of 20%
over a time period of 2 years for glass ceramic implants
used in facial recontouring. Despite the authors’ positive
resumeethiscomplicationrateseemstoohigh.Reviewers
criticizethatclinicallong-termresultsareespeciallypoor
in cases of especially voluminous bone substitution,
consecutively showing poor vascularization[106], [163].
Just as titanium implants, the glass-ceramic Bioverit
®
established in ear-surgery by Beleites et al. [10] is avail-
able as an individual CAD/CAM implant for craniofacial
reconstruction showing good clinical results [11], [137].
Theimplantsallowintraoperativeremodellingandadjust-
ment with a bur and, in opposite to titanium implants, do
not show thermosensitivity.
3.3.2.2 Calcium phosphate
This comprises: Hydroxyapatite, tricalcium phosphate,
biphasiccalciumphosphate(acompoundofthetwopre-
mentioned) und unsintered calcium phosphate. Calcium
phosphatesdonotcauseinflammatoryreactionorforeign
body response and also are nontoxic. Basically, all Calci-
um phosphates are osteoconductive. Solubility and cell-
mediated degradationunderlie multifactorial influences,
e.g.theyaredependantonthedifferentcomponentsand
themanufacturingdetails(amongstotherssintering)[96].
Hydroxyapatit (HA)
The name “apatite” is based on Greek ápatan, “to de-
ceive”, as it is easily confused with minerals of similar
appearance.Hydroxyapatite(Ca10(PO4)6(OH)2)canbefound
as a natural, inorganic component of teeth and bones
and therefore is biocompatible. The hexagonal crystal
system consists of calcium phosphates and can be
manufactured synthetically through sintering. Sintering
is a method for making objects from powder, by heating
thematerialinasinteringfurnacebelowitsmeltingpoint.
The source material can also be allogenic or xenogenic
cancellous bone or even be phykogenic (corals).
HA is already in clinical use for approx. 30 years. Since
1993 it is available as porous granules [26], since 1992
as cement (non-ceramic form) [35]. The hydroxyapatite
cement (HAC; BoneSource
®, Stryker Leibinger) consists
of a solid (tetra calcium phosphate and dicalcium phos-
phate) and a liquid component (water), which show iso-
thermal setting within 20–30 mins after mixing. The cur-
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a: Pre- and b: Postoperative (6 months) condition in CT scan
ing may be accelerated by a sodium phosphate buffer.
During the curing process the cement must not gain
contact to any fluids (blood) [124]. Critics claim that a
dryoperatingfieldispracticallynon-existentincraniofacial
surgery [93]. Other cement types (Norian SRS
®, Synthes)
consist of modified components (mono calcium phos-
phate)andthereforeshowdifferentcuringtimes,physical
and resorption characteristics etc. [59], [168], [134]
(also see chapter 3.3.2.2, presentation Maier http://
www.egms.de/en/journals/cto/2011-8/
cto000059.shtml).
HAisosteoactive,meaningitcanbetransformedintovital
bone mass by means of osteoinduction or osteoconduc-
tion. The non-linear resorption and the ingrowth of bone
mass could last approx. 18 months. The question if the
materialisreplacedbybonesubstancedependsonform
(ceramic vs. non-ceramic), porosity and volume.
InanimaltestsGosainetal.[64]describednosignificant
ingrowth of bone substance into HAC-filled calvarian de-
fects after a period of one year. The possibility of intraop-
erative forming and remodellingis still consideredas the
essential advantage of the cement [63], however appar-
ently it only shows little to no transformation into vital
bone substance. Porous HA-granulae, which were mixed
with blood and the implanted into 200 patients also
showed no resorption after a period of 8 years [26] so
that it is now regarded to be reliable for augmentations.
Overall the resorbability of HA is considerably poor.
Even though HA shows high compressive strength
(60MPa) it has low flexural and torsional strength.
Therefore it is especially suitable for bone replacement
withlowtonomechanicalstress(cranioplasty,skullbase
defects, aesthetic augmentations). Successful implanta-
tions have also been described for “unsterile” areas
(sinuses, mastoid, Figure 6) [57], [116], [130] including
sealing of frontobasal CSF-filstula [37]. Contact between
thehardenedcementandthecerebrospinalfluidappears
to be unproblematic [94].
Long term results of frontal sinus obliteration using HAC
are unsatisfactory, especially because of late infections
[106], [110], [153]. Our own initial enthusiasm using
hydroxyapatite for frontal sinus obliteration [116] was
also dampened due to late infections in 1 of 4 cases
making us have to remove the material. Zins et al. also
advise against replacing “full-thickness cranial defects”
by HAC due to high complication rates [169].
Beta-Tricalcium phosphate (β-TCP)
β-Tricalcium phosphate (Ca3(PO4)2) also is a natural com-
ponent of bone. It has interconnecting pores of different
sizes.Unlikeceramichydroxyapatite,β-TCPshowsresorp-
tion within 0.5–2 years [81]. As a consequence of the
resorption occurring faster than the production of new
bone, fibrous interlayers may result which reduce the
mechanical stability. The combination of β-TCP and os-
teoinductive agents aims to reduce this disproportion of
resorption and replacement [22]. Furthermore, modern
syntheticmanufacturingproceduresallowacombination
of interconnecting micro- (0.5–10 µm) und macropores
(50–700 µm) which aims to improve the dynamics of
substitution.Thevarietyofβ-TCPmorphologyconcerning
porosity, particle size, phase purity and microstructure
leads to many different biological interactions [122]. To
date β-TCP are mainly applied in dental surgery.
3.3.2.3 Aluminum oxide
Aluminum oxide (Al2O3) is the prototype of bioinert mater-
ials (survey see [44]). It is practically poreless and has
neither osteoconductive nor osteoproductive properties.
As such it is excellently appropriate to serve as ossicular
replacement in reconstructive middle ear surgery [79],
[125]. Otherwise its applications in craniofacial recon-
structionare limited. Jahnke reported applicationsin the
reconstruction oft the anterior skull base in cere bro-
spinal fluid leakage repair [80].
3.3.2.4 Calcium sulfate
Calcium sulfate (plaster of Paris) is the oldest ceramic
bone substitute (Dreesmann 1892 [45]). It sets via an
exothermic reaction, has a low compressive strength (24
MPa) and is resorbed within only 2 to 6 months). There
are only few reports on clinical applications as bone
substitute in craniofacial reconstruction [34], [40]. A
porousbonesubstitutecomposedof51.5%nano-crystal-
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following HTR implantation for calvarian repair
line hydroxyapatite and 48.5% calcium sulfate (Peros-
salTM) has been approved especially for drug release
functions (e.g. antibiotics in osteomyelitis) in other med-
ical subspecialties [48].
3.3.3 Plastics
3.3.3.1 Acrylate
HTR
HTR(hardtissuereplacement)sinteredpolymersconsist
of poly-methyl methacrylate (pMMA), poly-hydroxyethyl
methacrylate (pHEMA) and calcium hydroxide, whereas
only the latter two gain contact to the outer surface of
thebiomaterial.Theoperationalbiomaterialischaracter-
ised by its porosity (pore size 250–500 µm, material
porosity: 30%), hydrophilic surface, negative surface
tension (up to –15 mV) and high compressive strength
(approx. 70 MPa). The porosity allows the ingrowth of
blood vessels and connective tissue and therefore facili-
tates a firm fixation to the surrounding tissue. Prior to
implantation the porous material may be imbued with
fluids (e.g. antibiotics) which are then released in situ.
The biological effect of the negative surface tension is
currentlyunknown,possiblyitpreventsbacterialadhesion
and supports tissue ingrowth [32], [53]. Different from
autogenic bone material (for which resorption is de-
scribed) methacrylates remain at a constantvolume and
are not absorbed [103].
HTR are available as blocks, granula or preformed im-
plants.Theymaybeusedforprimaryreplacementofbone
resection defects if the dimension of the resection is
knowninadvance,e.g.casesoflargebonetumours[53].
For this purpose synthetic resin models are made preop-
eratively based on CT-scan data (takes up to 3 days) on
which the surgeon demarcates the planned resection
outlines.Themanufacturer–onceagainafterafewdays
–thendesignsaCADandCAMaided“hardtissuereplace-
ment – patient matched implant” (HTR-PMI, Figure 7).
Nowadays the entire planning procedure can be carried
outonline.Incasetheintraoperativeboneresectiondoes
differ from the preoperative template, the HTR-PMI can
be either burred or else modified or amended with small
autologoustransplants.The implantis fixatedwith titani-
um plates or resorbable plates and screws. Clinical use
ismainlyforlargebonedefectswhereextensiveamounts
of autologous bone would have to be harvested. Disad-
vantages surely are the costs (from 3,000 € per implant)
and the delivery time of the implant (approx. 18 days).
Worldwide many thousands of such implants have been
usedsofar.Earlyreportedcomplicationratesofacrylates
of up to 12% (1970s) [27], [161] have not been con-
firmedforHTR-PMIinlongtermstudies[53].Theinfection
rate is increased in patients with pre-existing infections
of the implant site [32] so that a history of infection is
regarded as a contraindication.
3.3.3.2 Porous polyethylene
Porous polyethylene (PPE) or high density polyethylene
(HDPE, Medpor
®, Porex Surgical) is a linear highly com-
pressed (sintered) aliphatic hydrocarbon. Pore-size and
pore-volume are similar to those of HTR so that PPE also
allows tissue ingrowth. PPE is inert and biocompatible
(see page chapter 3.3.2.4, presentation Maier http://
www.egms.de/en/journals/cto/2011-8/
cto000059.shtml),itispreferablyusedforfacialaugment-
ation [13]. After heating up it is deformable so that indi-
vidualremodellingandreshapingbybendingandcutting
are possible.
HDPE has been successfully used for various indications
in bone replacement surgery: Post-traumatic or tumour
resection defects of the calvarium, orbit, mandible and
alsoaestheticaugmentation(e.g.chin).Therateofinfec-
tions making a removal necessary was 3% of a total of
162patients[165].Otherauthorsreportedinfectionrates
of up to 6% [30]. For a most successful implantation
subperiostal positioning of the material and subsequent
fixation with osteosynthesis screws is generally recom-
mended to prevent relative movement. The ingrowth of
bloodvesselsallowsdirectonlay ofskintransplantsonto
the implant [160].
3.4 Composites
Theaimofcompositematerialsisasynthesisoftheoften
opposing osteoconductive and mechanical properties
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ites as it consists of an organic scaffolding (mainly colla-
gen), anorganic matter (hydroxyapatite) and also growth
factors and cytokines.
There are manifold possibilities of combining materials,
some examples being:
Combinations of materials:
• Titaniummeshwithhydroxyapatitecementascalvarian
substitute.Durapulsationsthatcouldhinderthecuring
process of the hydroxyapatite cement are retained by
the underlying titanium mesh [36], [59], [105].
• Resorbable mesh with hydroxyapatite cement as cal-
varian substitute [25].
• Titanium mesh with autogenic bone for mandibular
reconstruction [98].
Composite materials:
• A mixture of hydroxyapatite and beta-tricalcium phos-
phate (60:40) interconnected by a silicon dioxide
matrix (Bonit
®, DOT GmbH Rostock) combines the
positivepropertiesofcalciumphosphateandbioglass.
Due to the high proportion of nano-crystalline calcium
phosphateparticlesthematerialismoreeasilyresorb-
able than sintered β-TCP. It forms an osteoconductive
scaffolding because of the interconnecting pores
(porosity 60–70%). It is available for mandibular de-
fects or sinus lift either preformed or as granulae.
• Low temperature sintered (200°C) highly porous ma-
terial consisting of 76% calcium phosphate and 24%
silicon oxide (NanoBone
®, Artoss GmbH Rostock)
showedgoodosteoconductivityandresorptionproper-
ties in animal experiments [73]. First clinical applica-
tions provide a promising outlook [149].
Furtherexamplesforcompositematerialscanbefoundin
chapter3.3.2.3,presentationMaierhttp://www.egms.de/
en/journals/cto/2011-8/cto000059.shtml.
3.5 Recent developments
Hormonal influence on bone regeneration
The very complex bone metabolism is influenced by a
variety of factors [104]: Systemic influence is through
vitaminD,parathyroidhormone,calcitonin,localinfluence
through TGF-β especially BMP, IGF, TNF-α, interleukins.
BMP (bonemorpogeneticproteins)promotethedifferen-
tiation of undifferentiated mesenchymal cells into pre-
osteoblasts and osteoblasts. BMP can be extracted from
bones or can be produced my recombinance. To date,
recombinantBMP-7 (OP-1
®, Stryker) is the onlyapproved
compound and has been evaluated in many non-
craniofacialapplications.Theoreticallyitcanbecombined
with various biomaterials in order to enhance their os-
seous integration or substitution [126], [167]. According
to the product information OP-1
® should only be applied
when other therapy methods have already failed, e.g.
poor fracture healing/absent callus formation. The num-
ber of craniofacial indications is somewhat limited, as
the pre-mentioned problems are mostly caused by im-
paired circulation which rarely occurs in the head-and-
neckregions.Anotheraspectistheimprovedosseointeg-
rationofdentalimplantsandprostheses.Possiblecarriers
for BMP are collagen, demineralised bone, synthetic
bioabsorbablepolymers,calciumphosphateandsurface-
coated metals.
Surface modification
Surface modification of various materials (e.g. photolito-
graphy)andselectiveplasmacoatingmayleadtodirected
adhesion and cellular ingrowth. Especially the BMP-
coating establishes many possibilities for improved and
accelerated osseointegration of implants [82]. The sur-
face coating restricts the effects to remain local effects
hence preventing ectopic bone formation.
Tissue engineering
Just like in other medical subspecialties tissue engineer-
ing will increasingly gain in importance in the field of cal-
varian surgery. Autologous stromal bone marrow cells
have already been successfully applied in a compound
with calcium alginate gel for the repair of parietal bone
defects in animal experiments (sheep) [135]. “Adipose
derived stemcells” also show great osteogenic potential
[3].Commerciallyavailable“tissueengineeredbone”has
repeatedly been announced yet still is not ready for the
market so far.
Bifocal distraction osteogenesis
Bifocal distraction osteogenesis describes a technique
of shifting a small transport segment (autologous bone),
which is much smaller than the actual defect, approx.
1 mm per day, thereby practically “stretching” the callus.
Animal experiments showed successfulrepair of “critical
size defects”, however the substitute-bone was thinner
than the surrounding calvarium [87].
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